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AbsTrACT
Objectives the detection of an Sti agent in a 
urogenital tract (Ugt) specimen from a young child is 
regarded as being indicative of sexual abuse. However, 
the probabilities of contamination events that could 
conceivably lead to Sti positive specimens in the absence 
of sexual contact are unclear. the objective was to 
estimate the potential for fingers that have come in 
contact with Chlamydia trachomatis-positive urine to 
detectably contaminate C. trachomatis-negative urine.
Methods the study design was based on self-
experimentation. Dilutions of C. trachomatis elementary 
bodies (eBs) were prepared. a participant contacted 
an eB dilution then a urine surrogate specimen. the 
experiment was performed by three participants using 
three C. trachomatis isolates, of genotype e, F and B. 
two surrogate urine contact methods were used to 
mimic contamination of a carer assisting with a child’s 
urine collection. all eB dilutions and urine surrogate 
specimens were subjected to C. trachomatis assay and 
quantification in a real-time Pcr-based diagnostic 
system.
results the amplimer crossing point (cq) for eB 
dilutions was 10.0±1.6 less than for corresponding 
finger contacted urine specimens, which corresponds to 
~10 µl of eB suspension transferred. this was largely 
independent of participant identity, C. trachomatis 
strain or eB dilution. Hand decontamination led 
to large reductions in eBs transferred, but transfer 
remained consistently detectable. recent cq data 
from C. trachomatis-positive clinical urine specimens 
were collated, and 20% clearly contained sufficient C. 
trachomatis to detectably contaminate another specimen 
by finger-mediated transfer, as in this experiment.
Conclusions this study directly demonstrated the 
potential for urine contaminated fingers to convert a C. 
trachomatis-negative urine specimen to C. trachomatis 
positive as a result of contact. accordingly, procedures 
for urine specimen collection, particularly from children, 
need to be designed to prevent contamination.
InTrOduCTIOn
The exquisite sensitivity of nucleic acid amplifica-
tion tests for STIs can lead to the perception that 
positive results can arise from specimen contami-
nation events. This is particularly significant in the 
Australia’s Northern Territory (NT). Approximately 
30% of the NT population are Indigenous Austra-
lians, with about half living in remote communities. 
The notification rates for STIs are high in the 
NT, especially in the Indigenous population. For 
example, the rate of Chlamydia trachomatis notifi-
cations in Indigenous people in the NT is approxi-
mately five times higher than the notification rate in 
the Australian population as a whole.1
The ‘Little Children Are Sacred’ report from 
20072 detailed widespread concern of child sexual 
abuse in NT remote Indigenous communities. This 
led to large-scale and controversial interventions 
by the Australian Commonwealth Government, 
which are ongoing in modified form. Long-standing 
tensions between the imperatives of child protec-
tion and avoidance of disruption and stereotyping 
of communities and families remain.3 This may 
manifest in difficulties formulating service provider 
responses to instances of detection of STI agents in 
the urine of young children, when there is no other 
evidence of sexual abuse. While recognising that an 
STI in a child is a strong indicator of sexual abuse, 
an absence of other indicators can lead some service 
providers to raise the possibility of a urine specimen 
or anatomical site contamination. Studies outside 
Australia have lent credence to this concept.4–6
We are investigating conceivable mechanisms 
that diagnostic specimens may become contami-
nated. We have previously reported the potential of 
contaminated toilet–bathroom facilities to give rise 
to contaminated specimens,7 and also addressed 
the question as to whether C. trachomatis derived 
from ocular infections rather than sexual contact 
Key messages
 ► Human fingers contaminated with Chlamydia 
trachomatis can detectably contaminate urine 
surrogate specimens by contact.
 ► The relationship between level of finger 
contamination and urine surrogate 
contamination is highly consistent.
 ► Three contaminated fingers, dried on paper 
towel, transfer the equivalent of approximately 
10 µL C. trachomatis suspension to a urine 
surrogate specimen.
 ► It is critical that urine specimen collection 
procedures, in particular from children, should 
be in accordance with procedures designed to 
prevent contamination from any source.
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can be reliably identified by genotyping.8 9 Here, we test another 
conceivable mechanism; that a carer with C. trachomatis 
contaminated fingers who assists a child to provide a urine spec-
imen may convert a specimen from C. trachomatis negative to C. 
trachomatis positive, as a result of contact between their fingers 
and the specimen.
MeThOds
The study design basis was simulation by self-experimentation 
performed by three members of the investigator team (termed 
participants). Three C. trachomatis isolates were used. They 
were all derived from the ‘Mother-Child’ study, a survey of 
C. trachomatis in mothers and their babies, performed in the 
north of the NT between 1986 and 1992.10–12 Isolate E_Aus56 
is serovar E, isolate F_Aus51 is serovar F and isolate B_Aus45 is 
serovar B. All three are urogenital tract isolates and B_Aus45 has 
been genome sequenced.12
Each participant contacted suspensions of live C. trachomatis 
with their bare fingers, and then immediately after contacted a 
10 mL aliquot of a urine surrogate solution, made as described 
by Martino and coworkers.13 The relative quantities of C. 
trachomatis DNA in the suspensions and urine surrogate solu-
tions were then determined. The experimentation was performed 
on three different days, with 2 weeks between each occurrence. 
On each day of experimentation, a single C. trachomatis isolate 
was tested with all three participants. In advance of experimen-
tation, the isolate to be used was grown to high infection levels 
in McCoy cells (90%–95% of host cells infected) as previously 
described.12 Elementary bodies (EBs) were released from host 
cells and concentrated, as previously described,12 and a 100-fold 
dilution series in urine surrogate prepared yielding dilutions 
of 100–10−12 for E-Aus56 and F_Aus51 and 100–10−14 for B_
Aus45. Between 30 and 60 min in advance of the experiment, 
the experimenters washed their hands in a general purpose hand 
and body wash (Avagard 9230-D (3M)), rinsed with tap water, 
then rinsed their hands with 0.5% chlorhexidine gluconate in 
70% ethanol (Avagard 9250 P (3M)) and allowed this to dry.
Two different methods of contact between the experimenter’s 
C. trachomatis contaminated fingers and urine surrogate were 
used: (1) dipping the contaminated fingers into 10 mL urine 
surrogate in a urine pot for 10 s (method A—dipping method 
(performed first, using the left hand)) and (2) running 10 mL of 
urine surrogate over the contaminated fingers into a container 
(method B—pouring method (performed second, using the 
right hand)). These methods were first used to generate nega-
tive control (N1) specimens, where there was no prior contact 
between fingers and an EB suspension on that day. Then, 
commencing with the most dilute EB suspension, the partici-
pant contacted each EB dilution with the first, second and third 
fingers, dried the fingers briefly on a paper towel, then contacted 
a 10 mL urine surrogate specimen with the same fingers. On 
completion of both contact methods with all dilutions of EB 
suspension, the participant decontaminated their hands using 
the same procedure as the pre-experimentation hand decon-
tamination. After this, on the same day, the participant gener-
ated ‘postexperiment, postdecontamination’ (N2) specimens by 
contacting fresh 10 mL urine surrogate with the same fingers 
of each hand as had been used previously. In this instance, the 
dipping method was used with both hands.
In the interests of practicality and safety, each experiment was 
performed using a class II biosafety cabinet by participant and 
two assistants. This ensured the participant touched nothing 
with their fingers in the course of the experiment apart from the 
EB dilutions, the urine surrogate samples and the paper towel 
used for drying.
The EB dilutions and the urine surrogate specimens were all 
subjected to analysis for C. trachomatis DNA, using the Roche 
Molecular Diagnostics Cobas 4800 CT/NG commercial diag-
nostic system (Roche Diagnostics Australia). This provides 
quantitation information in the form of the amplimer concen-
tration ‘crossing point’ (Cq). Provided there is doubling of the 
amplimer concentration with each PCR cycle, the Cq is inversely 
proportional to the log2(amplimer), with a gradient of −1. In 
general, Cq results ≥40 were not included in subsequent anal-
yses. We reasoned that results right at the limit of detection of 
the Roche instrument are potentially due to contamination from, 
for example, the air in the biohazard hood, and may confound 
rather than enhance our efforts to reliably determine the rela-
tionship between C. trachomatis loads in EB suspensions and 
corresponding finger-contacted urine surrogate specimens. 
Similarly, Cq values from positive reactions where a less diluted 
EB suspension yielded a negative reaction were excluded from 
further analysis. All results, including those from specimens that 
yielded positive results with Cq values ≥40, are presented in the 
supplementary data.
The difference between the Cq for an EB suspension and the 
Cq for a corresponding finger contacted urine surrogate spec-
imen was defined as the ΔCq. Assuming amplimer doubling 
with every PCR cycle, the volume of EB suspension transferred 
to the urine surrogate (in µL)=10 000/2ΔCq, where 10 000 is 
the volume of each urine surrogate specimen in µL and 2ΔCq 
is the ratio of target concentration between EB suspension and 
derived urine surrogate specimen. A similar approach was used 
to calculate the reduction in C. trachomatis load on the fingers 
concomitant with hand decontamination after the completion 
of the transfer experiment. In this case, the parameter ΔCq(N2) 
is the difference between the Cq value for a urine surrogate 
specimen arising from transfer from the undiluted EB suspen-
sion (ie, the final data point in the transfer experiment) and the 
Cq for the urine surrogate specimen contacted by the postde-
contamination fingers. The numerical reduction in load is thus 
2ΔCq(N2).
The statistical methods used were primarily one-way analysis 
of variance (ANOVA) and Tukey ‘Honest Significant Difference’ 
(HSD) for comparisons of more than two categories and the 
t-test for comparison of two categories. In general, ΔCq values 
were used rather than calculated values for volumes of EB dilu-
tion transferred. This is because the statistical methods used are 
reliant on normal distribution of data. It was determined that 
the distribution of ΔCq values was consistent with normality, 
according to the Shapiro-Wilks test (p=0.92). In contrast, the 
distribution of deduced transferred volumes was inconsistent 
with normality, with a long tail towards high values.
resulTs
Initial inspection of the data revealed a consistent relationship 
between the Cq values derived from EB suspensions, and Cq 
values derived from the corresponding finger contacted urine 
surrogate specimens. Results from a typical experiment are 
shown in figure 1, and all results are shown in supplementary 
information.
We tested the assumption that there was amplimer doubling 
in every PCR cycle. A linear regression of log EB dilution versus 
Cq for all Cq values <40 was performed. This yielded Cq=3.3 
× log EB dilution +16.0 (R2=0.98). Because 3.3 = log210, it 
was concluded that the assumption of target doubling in each 
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PCR cycle is justified, so allowing the volumes of EB suspensions 
transferred to be calculated as described in the Methods.
Collated results from all specimens apart from the N1 pre-ex-
perimentation specimens and the N2 posthand decontami-
nation specimens are summarised in table 1. In accordance 
with the Methods, six Cq values from finger contacted urine 
surrogate specimens were excluded from analysis as they had 
Cq values≥40 (three specimens), yielded positive reactions 
where a less diluted EB specimen yielded a negative reaction 
(one specimen) or fulfilled both criteria (two specimens) (see 
online supplementary data). The mean ΔCq value across the 
entire experiment (not including the N1 and N2 specimens) was 
10.0±1.6, which equates to ~10 µL of EB dilution being trans-
ferred to the urine surrogate specimens, with an inferred range 
of volumes transferred being ~1–100 µL. The ΔCq values from 
participant 1 were significantly lower than the ΔCq values from 
the other two experimenters, indicating that participant 1 trans-
ferred significantly more EBs than the other two. Similarly, the 
ΔCq for the pouring method was slightly but significantly less 
than for the dipping method. In contrast, there was no signifi-
cant difference in the ΔCq values between the three different C. 
trachomatis strains. The 10−2 dilutions gave rise to significantly 
higher ΔCq values than either the undiluted suspension or 10−4 
diluted suspension.
The C. trachomatis diagnostic test yielded a positive reac-
tion for five of the 18 N1 specimens, with Cq values ranging 
from 39.6 to 40.8 (see online supplementary data for complete 
results). All the positive reactions were from specimens obtained 
immediately before the pouring experiments, after the dipping 
experiment had been completed.
All of the N2 postdecontamination specimens yielded posi-
tive PCR reactions, with Cq values ranging from 32.5 to 40.0. 
After exclusion of the single Cq value of 40.0, the reductions in 
C. trachomatis DNA resulting from hand decontamination were 
quantified. The mean of the ΔCq(N2) values was 10.3±2.1, with 
an absolute range of 6.4–14.8. This equates to a mean reduction 
of 1271-fold and an absolute range of 85.0-fold to 28526-fold.
To assess the clinical implications of this study, we compared 
our results to 30 successive Cq values from analysis of speci-
mens analysed in the course of clinical service provision. The Cq 
values were derived from the same instrument as used to analyse 
the urine surrogate specimens in this study. We conservatively 
classed any specimen with a Cq <40–10=30 as clearly having 
potential to contaminate a finger sufficiently to potentially give 
rise to a false positive. Six of the 30 (20%) of the Cq values 
were ≤30, indicating that such potential exists.
dIsCussIOn
The principal finding was remarkably consistent ΔCq values 
of ~10 cycles, with respect to the EB suspensions and corre-
sponding finger-contacted urine surrogate specimens. This was 
largely independent of suspension density, C. trachomatis isolate, 
participant identity or EB transfer procedure. Comparison with 
Cq values from a sample of C. trachomatis-positive urogenital 
tract (UGT) clinical specimens indicated that 20% of such spec-
imens can contaminate a human finger sufficiently to be able 
to convert a C. trachomatis-negative specimen to positive as a 
result of contact. While ΔCq values may provide an indication of 
the likelihood of detectable contamination of clinical specimens, 
to make the results more generalisable, we inferred the volumes 
of EB suspensions transferred from human skin to the 10 mL 
urine surrogate specimens. The self-experimentation procedure 
Figure 1 Typical result from an EB transfer experiment for one 
strain, with the solid line representing Cq values from dilutions of an 
EB suspension and the dotted  line representing the mean Cq from the 
corresponding finger contacted urine surrogate specimen, for all three 
participants. EB, elementary body.
Table 1 Ranges of ΔCq values and inferred volumes of EB dilutions transferred
Category (n) Mean ΔCq (sd) ΔCq range
Mean µl transferred (inferred from±2xΔCq sd 
range)(inferred from observed ΔCq range)
All (49) 10.0 (1.6) 6.7–13.3 9.8 (1.1–89.7)(1.0–96.2)
Participant 1 (17) 8.8 (0.9) 6.7–9.8 22.4 (6.4—78.1)(11.2–96.2) p<0.0001*
Participant 1 vs participant 2: p<0.01†
Participant 1 vs participant 3: p<0.01†
Participant 2 vs participant 3: not significant†
Participant 2 (16) 10.5 (1.2) 8.6–13.0 7.1 (1.4–32.6)(1.2–25.8)
Participant 3 (16) 10.9 (1.6) 7.7–13.3 5.2 (0.6–48.1)(1.0–48.1)
Dipping (23) 10.6 (1.7) 7.4–13.3 6.4 (0.6–68.0)(1.0–59.2) p=0.015‡
Pouring (26) 9.5 (1.3) 6.7–12.4 13.8 (2.3–83.7)(1.0–96.2)
E_Aus56 (17) 9.7 (1.6) 6.7–12.2 12.0 (1.3–110.5)(2.1–96.2) Not significant; p=0.41*
F_Aus51 (15) 10.0 (1.6) 7.4–13.3 9.8 (1.1–89.8)(1.0–59.2)
B_Aus45 (17) 10.4 (1.5) 8.4–13.0 7.4 (0.9–59.2)(1.2–29.6)
Undiluted (18) 9.4 (1.7) 6.7–12 14.8 (1.4–156.3)(2.4–96.2) p=0.004*
100 vs 10−2: p<0.01†
100 vs 10−4: not significant†
102 vs 10−4: p<0.05†
10−2 diluted (18) 11.0 (1.5) 9.0–13.3 4.8 (0.6–39.1)(1.0–19.5)
10−4 diluted (13) 9.5 (1.0) 7.7–11.1 13.8 (3.5–55.2)(4.6–48.1)
The 49 data points were collated according to different criteria to reveal possible correlates. This encompasses data only from specimens that yielded a positive C. 
trachomatis test with a Cq <40.
*One way analysis of variance.
†Tukey HSD.
‡t-test (two tailed).
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transferred into each surrogate urine specimen C. trachomatis or 
DNA equivalent corresponding to a mean of 10 µL and a range 
of ~1–100 µL of EB suspension. It was shown that hand decon-
tamination reduced the amount of C. trachomatis DNA trans-
ferred from contaminated fingers by ~1000-fold, thus reducing 
potential for specimen contamination. The principal strength of 
the study is that it was a very direct test of the potential for 
C. trachomatis-contaminated fingers to contaminate diagnostic 
specimens, with the remarkable consistency of ΔCq values, indi-
cating integrity in the experimental design.
We considered whether the positive diagnostic tests for N1 spec-
imens (5/18) indicated that the experiment had been confounded, 
such as by pre-existing finger contamination. All five positive 
reactions were from specimens taken after the dipping method 
experiments and prior to pouring method experiments. This, in 
combination with extremely high Cq values, suggests the likely 
basis for the positive N1 reactions was aerosolised C. trachomatis 
inside the biosafety hood arising from the dipping method exper-
iments. While we cannot rule out that such contamination has 
impacted the experimental results, this can only be the case for 
specimens that gave Cq values close to 40 and will not have had a 
significant effect on the study outcomes.
The experimental design did not encompass a systematic 
determination of the persistence of C. trachomatis on the skin. 
This was primarily because it is unreasonable to expect a partic-
ipant to contaminate their fingers with live C. trachomatis and 
then refrain from hand decontamination for a long period 
of time. However, the results from the N1 specimens from 
the experiments carried out on the second and third days of 
experimentation provide some insight. The three experimen-
tation days were 2 weeks apart. No C. trachomatis DNA was 
detected in the N1 specimens that were obtained at the start 
of the second and third days of experimentation, indicating 
that no detectable finger contamination had persisted from the 
experimentation 2 weeks, or 2 weeks and 4 weeks prior. This 
is despite the N2 specimens obtained at the end of the exper-
imentation in experimentation days 1 and 2 being universally 
positive. Thus, between experiments on different days, the 
amount of C. trachomatis DNA on the fingers of the partici-
pants dropped below the level in which they could contami-
nate specimens. Given that hand decontamination reduced the 
amount of C. trachomatis/C. trachomatis DNA transferred by 
an average of ~1000, this is unsurprising.
The assumption implied by the data analysis method was 
that the quantitative PCR device accurately measured C. 
trachomatis DNA. However, this may not be justified. It was 
unexpected that the distribution of ΔCq values conforms 
to normality more closely than the distribution of inferred 
volumes transferred to the urine surrogate. The volume trans-
ferred is the physical phenomenon expected to be normally 
distributed, while the ΔCq is the product of a log transfor-
mation. This suggests that variation in the ΔCq values may 
encompass instrumental artefacts as well as variation in the 
volumes of amounts of EB suspensions transferred.
We observed that participant identity and EB transfer 
method are correlated with EBs transferred. We do not regard 
speculation regarding mechanisms as useful, as the effects 
are small and do not change translational implications. Also, 
we regard the higher ΔCq observed with the 10−2 dilutions 
of EB as not mechanistically meaningful. Phenomena such 
as a limited number of high affinity EB binding sites on the 
skin could reduce EB transfer below what would be expected 
when the EB density is low. However, there was no signifi-
cant difference between the ΔCq values arising from undiluted 
suspension and most dilute (10−4diluted) suspensions, so no 
evidence for loss of EBs at low EB densities. The similar results 
from three C. trachomatis isolates suggest that our results are 
generalisable to the species as a whole.
This study has directly shown that contact between contami-
nated fingers and urine specimens has potential to contaminate the 
specimen and underpin a positive C. trachomatis test. This provides 
justification for standardised procedures for collection of urine 
specimens from children, encompassing controlled environments, 
with clear guidance, and if possible, close supervision by clinical 
staff. In the absence of other measures such as wearing gloves, hand 
decontamination has been shown to greatly reduce the potential 
for specimen contamination. There must be clear instruction on 
hand washing and avoidance of contact with the urine specimen 
and interior of the container to all involved in collecting a child’s 
urine sample for STI testing. Regardless, a positive STI test in a 
child remains a strong indicator of child sexual assault necessitating 
further investigation by police, statutory child protection agencies 
and relevant forensic medical teams.
More broadly, this study adds to accumulating knowledge 
regarding mechanisms that could contaminate specimens, and so 
give rise to spurious STI positive results. Previous studies have 
focused on the potential for STI nucleic acid on clinic or labo-
ratory surfaces to find its way into specimens.4–7 The emerging 
picture is that such surface contamination is commonly found 
but rarely leads to STI positive specimens. The difficulty of 
proving a negative, plus the demonstration by Andersson and 
coworkers7 of a non-zero frequency of specimen contamination, 
justifies measures to control the environment and procedure for 
STI specimen collection and emphasises the benefits of specimen 
collection under controlled conditions, particularly from young 
children. This current study adds to the imperative for this, by 
showing that potential for contact between specimen and uncov-
ered skin should be avoided. In general, guidelines for urine 
specimens for STI testing simply specify ‘first catch urine’ and do 
not specify specific precautions for avoidance of urine contam-
ination. In the NT, poster material available to medical prac-
titioners specifies that patients ‘wash your hands with soap’.14 
This is not children specific, and the extent that this procedure 
is followed is unknown. The absence of such precautions against 
contamination of specimens from young children could poten-
tially be significant in the judicial system. Interestingly, guide-
lines for clean catch urine sampling, which is not used in STI 
testing, do specify avoidance of contact between specimens 
and fingers for example.15 Determining the most effective and 
culturally appropriate means of obtaining UGT specimens from 
young children while avoiding contamination risks could be a 
useful area for future research.
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